Related Experiment Video
Updated: Jun 26, 2025

11:32
Fabrication of Biologically Derived Injectable Materials for Myocardial Tissue Engineering
Published on: December 20, 2010
15.1K
Photocrosslinkable microgels derived from human platelet lysates: injectable biomaterials for cardiac cell culture
Sara C Santos1, Catarina A Custódio1, João F Mano1
1Department of Chemistry, CICECO - Aveiro Institute of Materials, University of Aveiro, Portugal. catarinacustodio@ua.pt.
Biomaterials Science
|May 13, 2024
Summary
Methacryloyl platelet lysates (PLMA) microparticles offer a promising injectable solution for cardiac tissue repair. These xeno-free microcarriers effectively support cardiac and endothelial cell attachment for myocardial repair applications.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Cardiovascular Research
Background:
- Cardiovascular diseases cause significant global morbidity and mortality.
- Myocardial ischemia (MI) leads to cardiomyocyte death and fibrotic scarring, impairing heart function.
- Injectable systems for *in situ* cell/molecule delivery are promising for myocardial tissue engineering.
Purpose of the Study:
- To develop and evaluate methacryloyl platelet lysates (PLMA) microparticles (MPs) as injectable systems for cardiac tissue repair.
- To assess PLMA MPs' capacity to serve as cell microcarriers for cardiac and endothelial cells.
- To investigate the xeno-free potential of PLMA MPs in cell culture.
Main Methods:
- PLMA microparticles were produced using droplet microfluidics.
- Cell attachment properties of PLMA MPs were evaluated.
- The capacity of PLMA MPs to function as cell microcarriers was tested in culture media without animal-derived serum.
Main Results:
- PLMA MPs exhibited excellent properties for cell attachment.
- PLMA MPs successfully served as cell microcarriers for cardiac and endothelial cells.
- The cell-carrying capacity of PLMA MPs was demonstrated in xeno-free culture conditions.
Conclusions:
- PLMA microparticles are a viable biomaterial for creating injectable systems for myocardial repair.
- These xeno-free microcarriers support cardiac and endothelial cell attachment and function.
- PLMA MPs represent a promising approach for advancing cardiac tissue engineering.

